• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Aug13
Salarius Pharmaceuticals released FY2025 Semi-Annual earnings on August 12 (EST) with actual revenue of USD 0 and EPS of USD 0
03:00
Salarius Pharmaceuticals released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4511 (forecast USD -46.8)
03:00
Jul9
Salarius Pharmaceuticals Conducting Seclidemstat Clinical Trial for MDS and CMML Patients
13:07
Jun11
Salarius Updates Merger Agreement with Decoy
12:39
May15
Salarius Pharmaceuticals released FY2025 Q1 earnings on May 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD 0 (forecast USD -701.9996)
03:00
Mar24
Salarius Pharma Reports $5.6 Million Net Loss in 2024, Considering Merger with Decoy Therapeutics
12:22

Schedules & Filings

Schedules
Filings
Aug18
Reverse Stock Split(EST)

1-for-15 Reverse Stock Split

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -957.83 K

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.71 M

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LPTX
2.332
+433.05%
+1.943
OPP.RT
0.0047
+74.07%
+0.002
QH
1.340
+61.41%
+0.510
CMCT
7.825
+56.19%
+2.815
SPRU
4.415
+44.75%
+1.365
DTSQR
0.2600
+44.44%
+0.080
MSGM
4.833
+44.27%
+1.480
FMFC
0.7931
+42.39%
+0.233
CMBM
3.151
+40.06%
+0.899
FTCI
10.070
+35.35%
+2.710
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy